Edny Inui
InvestorPartner at Palo Santo VC · Partner at Palo Santo
Carmel Valley, California, United States
Find your path to Edny
39 people in our graph share verified history with Edny — schools, employers, funds. One of them is your warm intro.
David BeyerunlockedEdny: together at Caribou Biosciences (2017–2020)
×3Edny: together at Gilgamesh Pharmaceuticals
×3Edny: together at Palo Santo
×4Edny: together at Caribou Biosciences
About
Edny Inui is a Partner at Palo Santo, a venture fund focused on psychedelic and novel CNS target therapeutics for mental health and brain disorders. Inui holds a PhD from the University of Michigan, where research addressed fibroblast growth factors in depression and circadian biology, and an MBA from the University of Chicago, and has worked in business development at Calico Life Sciences, Caribou Biosciences, and Acadia Pharmaceuticals. Inui also serves as a board member and observer for several biotech startups.
Partner at Palo Santo
Intro paths
→
In turn, Edny can intro founders to Palo Santo's investors below.
Palo Santo's investors · 2
Co-founders at Palo Santo
DG
Daniel GoldbergPartner
Experience
- Palo SantoPartnercurrent2023 — presentCarmel Valley, California, United States
- 2A BiosciencesBoard Observercurrent2025 — present
- Pickering Laboratories, Inc.Board Membercurrent2022 — presentMountain View, California, United States
- Gilgamesh PharmaceuticalsBoard Observer2025 — 2026
- Calico Life SciencesDirector of Business Development2020 — 2023
- Caribou BiosciencesDirector of Business Development2017 — 2020Berkeley, CA
- ACADIA Pharmaceuticals Inc.Senior Manager, Strategy and Business Development2016 — 2017San Diego
- BiomedtrackerSenior Biotechnology Analyst2011 — 2016San Diego, CA
- UC San Diego Skaggs School of Pharmacy and Pharmaceutical SciencesPostdoctoral Research Fellow2010 — 2011San Diego, CA
Skills & more
Strategic ThinkingStrategy5Management5LeadershipStrategic PlanningMultiple Therapeutic AreasLicensing StrategyOut-licensingIn-licensingBiotechnology55Neuroscience51Business Development2
+12 more
Molecular BiologyData AnalysisDrug DiscoveryLife SciencesPharmaceutical IndustryLaboratoryResearchGeneticsLifesciencesAnimal ModelsPharmacologyDrug Development- Certified Licensing Professional — Certified Licensing Professionals, Inc.
From Edny's professional profile.
Colleagues at Palo Santo VC
Adrienne Jo
Investor at Palo Santo VC
Ailsa Dalgliesh
Investor at Palo Santo VC
Charles Nichols
Investor at Palo Santo VC
Daniel Goldberg
Founder at Bridge Venture Fund
Gretchen Temeles
Investor at Palo Santo VC
Ingrid Vergara
Investor at Palo Santo VC
Jason Thomas
Partner at Bridge Venture Fund
John D. McCorvy
Investor at Palo Santo VC
Frequently asked questions
- Who is Edny Inui?
- Edny Inui is a Partner at Palo Santo, a venture fund focused on psychedelic and novel CNS target therapeutics for mental health and brain disorders. Inui holds a PhD from the University of Michigan, where research addressed fibroblast growth factors in depression and circadian biology, and an MBA from the University of Chicago, and has worked in business development at Calico Life Sciences, Caribou Biosciences, and Acadia Pharmaceuticals. Inui also serves as a board member and observer for several biotech startups.
- Where does Edny Inui work?
- Edny Inui is Partner at Palo Santo VC and Partner at Palo Santo.
- Where did Edny Inui go to school?
- Edny Inui studied at Massachusetts Institute of Technology (BS, Biology); University of Michigan (PhD, Neuroscience); The University of Chicago Booth School of Business (Master of Business Administration - MBA).
Same school
Also attended Massachusetts Institute of Technology2,000
Fred WilsonCo-founder & Partner at Union Square VenturesElad GilSolo general partner investing through Gil CapitalAileen LeeFounder & Managing Partner of Cowboy VenturesHemant TanejaCEO & Managing Director of General CatalystPhilippe LaffontFounder & CIO of Coatue ManagementNat FriedmanCo-lead of Meta Superintelligence Labs; co-founder of NFDG
+ 1,994 more
Also attended University of Michigan1,045
Erik TorenbergGeneral Partner at Andreessen Horowitz; founder of TurpentineGlen AndersonPartner at Monta Vista CapitalAlexandra FarmerPrincipal at Intel Capital, North AmericaScott ShawChief of Staff at Intel CapitalZach PoleyPartner and Chief Technology Officer at Clear VenturesTom DanilekPartner, Rise of the Rest Real Estate at Revolution
+ 1,039 more
Also attended The University of Chicago Booth School of Business945
Prashant ShahPartner at Monta Vista CapitalNoorPartner at Clear VenturesTinaInvestments & Portfolio Services Team Member at Clear VenturesKatrin GeyskensExecutive Director at Capricorn Venture PartnersBill PescatelloInvestor at LightbankGlebFounder and Managing Partner at iTech Capital
+ 939 more
Shared employers
Also worked at Gilgamesh Pharmaceuticals11
Dakin SlossFounder & General Partner at Prime Movers LabJustin BriggsScientist, entrepreneur, and investor building companies at the nexus of biology, chemistry, and engineeringAmy KruseVenture Partner at Prime Movers LabTim SchlidtCofounder at Palo SantoMolly LawrenceVice President, Human Resources, Life Sciences at Bain Capital Life SciencesJonathan SpornFounder at Gilgamesh Pharmaceuticals
+ 5 more
Also worked at Calico Life Sciences4
Also worked at Caribou Biosciences6
David BeyerPartner at Amplify PartnersPhilip AustinManaging Partner and Co-Founder at Anterra CapitalJenny RookeManaging Director at Genoa VenturesScott BraunsteinVice-Chairman of the Board and Director at atai Life SciencesRodolphe BarrangouCo-founder at Ancilia BioDavid BeyerGeneral Partner at Amplify Bio
Also worked at ACADIA Pharmaceuticals Inc.6
Damien McDevittPresident and Chief Executive Officer at Aspen NeuroscienceMichael MagnaniExecutive Officer, Director at SaranasErin FoffExecutive Officer at MapLight TherapeuticsEliseo O. SalinasPresident and Chief Scientific Officer at Relmada TherapeuticsRob AcklesChief People Officer at AdarxKimberly J. ManhardExecutive Vice President, Chief Development Officer at Connect Biopharma
